Creative Biolabs-Immuno-oncology

Anti-CD44 (clone CD4I4Iv4I/1G2E1G9Q) SynExpress T7-R-I4-H Modified CD8+ T cells (CAT#: ITS-1224-CR1578)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44 (clone CD4I4Iv4I/1G2E1G9Q). We employs the pUC (T7-RFP-IL-4-HindIII) vector components and the SynExpress system of the Exons Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD44
Clone
CD4I4Iv4I/1G2E1G9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Prime Editing
Modification Domain
Exons
Carrier Type
pUC
Transformation Accuracy
0.96
Cell Culture
Plate Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.